Adaptive Biotechnologies (NASDAQ:ADPT) Coverage Initiated at Craig Hallum
Equities research analysts at Craig Hallum assumed coverage on shares of Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) in a research note issued to investors on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $15.00 price target on the stock. Craig Hallum’s price target would suggest a potential upside of 43.27% from […]
Equities research analysts at Craig Hallum assumed coverage on shares of Adaptive Biotechnologies (NASDAQ:ADPT – Get Free Report) in a research note issued to investors on Wednesday, Marketbeat reports. The brokerage set a “buy” rating and a $15.00 price target on the stock. Craig Hallum’s price target would suggest a potential upside of 43.27% from […]
